[144] RINGCENTRAL, INC. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for RingCentral, Inc. (RNG) shows an intended sale of 4,032 common shares through Morgan Stanley Smith Barney at an aggregate market value of $123,822.72, with an approximate sale date of 08/29/2025. The shares were acquired as Restricted Stock Units on 08/20/2025 and fully vested/paid the same day. The filing reports 80,738,182 shares outstanding, and discloses two recent 10b5-1 sales by Tarun Arora totaling 8,813 shares for gross proceeds of $249,970.39 on 06/27/2025 and 08/26/2025. The filer certifies no undisclosed material adverse information and references reliance on a trading plan where applicable.

Positive

• Disclosure includes broker and transaction details, aiding transparency
• Securities were acquired as RSUs with acquisition and payment dates clearly stated
• Previous 10b5-1 sales are disclosed, indicating preplanned, compliant dispositions

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, routine insider sale tied to RSU vesting; immaterial to company capitalization.

The notice documents a sale of 4,032 shares (~$124k) versus 80.7 million shares outstanding, indicating a de minimis dilution or market impact. The securities were acquired as RSUs on 08/20/2025 and are being sold shortly thereafter, suggesting liquidity needs or post-vesting diversification by the holder rather than a signal of company deterioration. Prior 10b5-1 executions totaling 8,813 shares in the past three months show a pattern of preplanned dispositions through a broker, which supports orderly selling. From a financial-materiality perspective, these transactions are routine and unlikely to affect valuation or capital structure.

Compliance/Risk Analyst

TL;DR: Filing appears compliant with Rule 144 and notes 10b5-1 sales; disclosure meets procedural requirements.

The form identifies broker, acquisition method (RSUs), acquisition and intended sale dates, and recent 10b5-1 sales, which are key elements for regulatory compliance. The signer represents no undisclosed material adverse information and references plan adoption dates where applicable, aligning with Rule 144 attestations. Given the explicit inclusion of 10b5-1 sales and broker information, procedural risk is low; no apparent omissions are visible in the disclosed fields. Materiality to investors is minimal based on disclosed volumes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4032	123822.72	80738182	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Restricted Stock Units	Issuer			4032	08/20/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TARUN ARORA 20 Davis Drive Belmont CA 94002	Common	08/26/2025	1037	32240.33
10b5-1 Sales for TARUN ARORA 20 Davis Drive Belmont CA 94002	Common	06/27/2025	7776	217730.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for RNG disclose?

The form discloses an intended sale of 4,032 RingCentral common shares through Morgan Stanley with an aggregate value of $123,822.72 and an approximate sale date of 08/29/2025.

When were the shares being sold acquired according to the filing?

The 4,032 shares were acquired as Restricted Stock Units on 08/20/2025, and payment/vesting is noted as 08/20/2025.

Who executed recent sales reported in the Form 144 for RNG?

Tarun Arora is identified for two 10b5-1 sales: 7,776 shares on 06/27/2025 for $217,730.06 and 1,037 shares on 08/26/2025 for $32,240.33.

How large is the proposed sale relative to shares outstanding?

4,032 shares represent a de minimis portion of 80,738,182 shares outstanding, indicating immaterial market impact based on disclosed figures.

Does the filing indicate any undisclosed material adverse information?

The filer certifies they do not know of any material adverse information about the issuer that has not been publicly disclosed.